- Scientists are planning for Phase 1 human trials of a vaccine they developed by using CRISPR gene-editing technology to mutate the parasite that causes leishmaniasis, a skin disease common in tropical regions of the world and gaining ground in the United States. https://news.osu.edu/something-old-something-new-combine-for-effective-vaccine-against-parasitic-skin-disease/ 13 comments science
Linking pages
- Vaccine protects against ‘tough cookie’ parasite found in the Americas https://news.osu.edu/vaccine-protects-against-tough-cookie-parasite-found-in-the-americas/ 89 comments
- Digging deeper into how vaccines work against parasitic disease https://news.osu.edu/digging-deeper-into-how-vaccines-work-against-parasitic-disease/ 2 comments
Linked pages
Related searches:
Search whole site: site:news.osu.edu
Search title: Something old, something new combine for effective vaccine against parasitic skin disease
See how to search.